BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12441910)

  • 1. The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism.
    Brown EW; Ravindran S; Patston PA
    Blood Coagul Fibrinolysis; 2002 Dec; 13(8):711-4. PubMed ID: 12441910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.
    Wallace EM; Perkins SJ; Sim RB; Willis AC; Feighery C; Jackson J
    Mol Med; 1997 Jun; 3(6):385-96. PubMed ID: 9234243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of C1-inhibitor polymers by denaturation and gel-filtration chromatography.
    Gauthier M; Patston PA
    Anal Biochem; 1997 Jun; 248(2):228-33. PubMed ID: 9177748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of C1-esterase inhibitor and plasmin in human euglobulin.
    Highsmith RF; Burnett CJ; Weirich CJ
    J Lab Clin Med; 1979 Mar; 93(3):459-71. PubMed ID: 155127
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.
    Harpel PC; Cooper NR
    J Clin Invest; 1975 Mar; 55(3):593-604. PubMed ID: 123251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor.
    Stief TW; Aab A; Heimburger N
    Thromb Res; 1988 Mar; 49(6):581-9. PubMed ID: 2455361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The native metastable fold of C1-inhibitor is stabilized by disulfide bonds.
    Simonovic I; Patston PA
    Biochim Biophys Acta; 2000 Aug; 1481(1):97-102. PubMed ID: 11004579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.
    Patston PA; Gettins P; Beechem J; Schapira M
    Biochemistry; 1991 Sep; 30(36):8876-82. PubMed ID: 1888745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1-inhibitor-serine proteinase complexes and the biosynthesis of C1-inhibitor by Hep G2 and U 937 cells.
    Patston PA; Medcalf RL; Kourteva Y; Schapira M
    Blood; 1993 Dec; 82(11):3371-9. PubMed ID: 8241507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 inactivator inhibition by plasmin.
    Harpel PC
    J Clin Invest; 1970 Mar; 49(3):568-75. PubMed ID: 4244455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse plasma trypsin inhibitors: inhibitory spectrum of contrapsin and alpha-1-antitrypsin.
    Takahara H; Sinohara H
    Thromb Res; 1982 Jul; 27(1):45-50. PubMed ID: 6214866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion.
    Cai S; Davis AE
    J Immunol; 2003 Nov; 171(9):4786-91. PubMed ID: 14568956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of C1-inhibitor function by binding to type IV collagen and heparin.
    Patston PA; Schapira M
    Biochem Biophys Res Commun; 1997 Jan; 230(3):597-601. PubMed ID: 9015369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.
    Björk I; Nordling K; Raub-Segall E; Hellman U; Olson ST
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):701-9. PubMed ID: 9794814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
    Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
    J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.